Chondroplasty addresses articular cartilage, not torn meniscus; NCCI bundling and whether work occurs in a separate compartment require careful review; the distinction is the record’s removal of damaged portion of meniscus versus the alternative of debridement or smoothing of joint cartilage.

Meniscal repair seeks healing of native fibrocartilage, unlike resection of the tear; separate compartments and concomitant work can affect reporting; the controlling finding is removal of damaged portion of meniscus, which is distinct from suture stabilization of meniscal tear.

Although Arthroscopic anterior cruciate ligament reconstruction may sound adjacent, it denotes placement of a graft to reconstruct the knee ACL rather than diagnostic inspection, cartilage trimming, or meniscal surgery; this record documents removal of damaged portion of meniscus, which is distinct from that alternative.

Temporary transvenous pacemaker placement is supported by documentation of short-term pacing lead and external generator rather than a newly implanted permanent system or its revision or exchange; here the decisive finding is repositioning of malfunctioning pacing lead; the defining work for this distractor is absent.

Initial pacemaker implantation establishes new generator and lead components; identify chambers and approach; it differs from changing an exhausted generator only; first-time generator and pacing lead implantation is not recorded; the evidence points to repositioning of malfunctioning pacing lead.

Extraction removes implanted cardiac device components; the scope is determined by what is actually removed and the technique used; this clinical evidence establishes repositioning of malfunctioning pacing lead, not explantation of infected implanted pacing hardware.

Drainage creates an outflow for a fluid collection rather than removing a solid pancreatic tumor; technique may be endoscopic or surgical and determines coding; to select this alternative the report would need internal drainage of matured pancreatic fluid collection, whereas it identifies resection of pancreatic body and tail.

EUS-guided fine needle aspiration obtains diagnostic material under ultrasound imaging; it is not a resection of pancreas or drainage of a pseudocyst; the reported work involves resection of pancreatic body and tail and does not establish EUS-guided fine needle sampling of pancreatic mass.

Pancreaticoduodenectomy is supported by documentation of major open resection of pancreatic head and adjacent duodenum rather than distal pancreatic removal, stent placement, cyst drainage, or FNA; here the decisive finding is resection of pancreatic body and tail; the defining work for this distractor is absent.

Prostate core biopsy samples gland tissue for histologic diagnosis; use code rules for biopsy technique and image guidance, rather than confusing it with surgical removal; the controlling finding is total oncologic removal of prostate, which is distinct from needle cores taken from prostate through rectum.

TURP removes tissue from inside the gland through the urethra; it is not complete removal of the prostate for cancer; the reported work involves total oncologic removal of prostate and does not establish transurethral shaving of prostatic obstructing tissue.

Although Prostatic cryoablation may sound adjacent, it denotes intentional freezing of prostate tissue rather than needle biopsy, transurethral resection, vaporization, or radical excision; this record documents total oncologic removal of prostate, which is distinct from that alternative.

Trial stimulation assesses benefit before permanent implantation; temporary leads are not equivalent to an implanted pulse-generator system; the patient record supports lasting stimulator generator with epidural leads rather than the alternative finding of temporary epidural neuromodulation electrode placement.

Generator exchange concerns an existing electrical device's power source; it should not be reported as first-time lead placement without evidence of lead work; to select this alternative the report would need exchange of implanted neurostimulator power unit, whereas it identifies lasting stimulator generator with epidural leads.

Revision of implanted spinal-stimulator lead corresponds to repositioning of an existing indwelling stimulation lead without placing a new trial system or replacing the generator; the record specifies lasting stimulator generator with epidural leads. Those details establish different classifications.

Stereotactic mammographic localization involves mammography-based targeting of a breast lesion rather than CT, ultrasound, fluoroscopy, or selective vascular angiography guidance; the note describes live radiographic tracking of intravascular catheter instead, changing the applicable classification.

CT guidance identifies the needle path and target in cross section; it is different from ultrasound visualization and is not automatically billable separately when bundled; the documented detail of live radiographic tracking of intravascular catheter prevents classifying it as CT localization during percutaneous needle passage.

Ultrasound guidance documents real-time localization of a needle; separate reportability depends on whether guidance is included in the underlying procedure descriptor; the controlling finding is live radiographic tracking of intravascular catheter, which is distinct from sonographic visualization of needle placement.

Therapeutic serum lithium quantification is supported by documentation of quantitative monitoring of a prescribed therapeutic medication rather than broad drug-of-abuse screening, alcohol level, or specimen adulteration testing; here the decisive finding is specific chemical identification by mass spectrometry; the defining work for this distractor is absent.

Presumptive testing provides initial class-level evidence and may have cross-reactivity; it is distinct from definitive mass-spectrometry identification; screening immunoassay for drug classes is not recorded; the evidence points to specific chemical identification by mass spectrometry.

Validity checks assess sample integrity and are not equivalent to testing for a therapeutic or illicit drug; separate coding depends on applicable payer policy; the documented detail of specific chemical identification by mass spectrometry prevents classifying it as evaluation of urine specimen integrity.

Selecting Intramuscular therapeutic injection would require delivery of medication into skeletal muscle rather than subcutaneous injection or intravenous push, infusion, or hydration; the actual document states timed IV fluid replacement for dehydration, which distinguishes the correct choice.

Subcutaneous medication administration follows an injection code pathway distinct from intravenous infusion; the supplied drug product may need additional reporting; this clinical evidence establishes timed IV fluid replacement for dehydration, not medication injected beneath skin.

IV push is not reported as a prolonged infusion simply because venous access was used; documentation should identify the route and actual administration method; the operative or visit note documents timed IV fluid replacement for dehydration instead of brief direct injection through IV access.

Selecting Time spent on a separately billed procedure would require minutes devoted to a distinct billed procedure that must be excluded from critical-care time; the actual document states stable routine ICU observation without critical illness, which distinguishes the correct choice.

Critical care requires the patient's critical condition, high-complexity decision making, and sufficient qualifying time; A 45-minute interval falls within the initial reporting range when all rules are met; the scenario instead describes stable routine ICU observation without critical illness, without demonstrating 45 minutes of qualifying physician critical care.

Eligible time from separate critical care episodes on the same date may be summed according to guidelines; time spent on nonqualifying or separately billed work is excluded; to select this alternative the report would need cumulative qualifying critical care time on one date, whereas it identifies stable routine ICU observation without critical illness.

QX describes the CRNA side of a medically directed anesthesia service under Medicare conventions; it differs from QZ when no medical direction applies; what was actually documented is medical direction of two to four concurrent cases, not the different evidence of CRNA service under medical direction.

Modifier AD is supported by documentation of medical supervision of more than four concurrent anesthesia procedures rather than personally performed anesthesia or defined direction and CRNA care; here the decisive finding is medical direction of two to four concurrent cases; the defining work for this distractor is absent.

AA identifies an anesthesiologist's personal performance under Medicare anesthesia billing conventions; it is distinct from medically directing a CRNA; to select this alternative the report would need anesthesiologist personally provides anesthetic care, whereas it identifies medical direction of two to four concurrent cases.

The meniscal tissue was actually sutured. Classifying the completed operation as diagnostic-only omits the substantive therapeutic work.

The record consistently describes arthroscopic ports and instruments; no open arthrotomy or open repair is documented.

This would double count the same arthroscopic inspection that is inherent in the therapeutic procedure without any independently reportable service.